STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
Gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company
Beam Therapeutics, a gene-editing company, is accusing one of its former scientists, Zi Jun "Emma" Wang, of intellectual property theft. Wang allegedly accessed Beam's electronic laboratory notebooks late at night and on weekends to gather information, which she then used to establish a new company, YolTech Therapeutics, in China.
The lawsuit was filed recently amid increasing tensions between American biotech firms and their Chinese counterparts. Beam Therapeutics' CEO, Eric Cantor, who recently took on this role, will face pressure from both political parties regarding drug prices as the Trump administration attempts to finalize voluntary agreements with various pharmaceutical companies to reduce U.S. medicine prices to those in other countries.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
